Lunai Bioworks Inc. Retains American Defense International
-
France star Mbappe calls for players to get more time off
-
Trump's Fed governor pick vows to uphold central bank independence
-
Norris brushes off Dutch setback before Italian GP battle with Piastri
-
In-form Breetzke stars as South Africa post 330-8 against England
-
France says 26 countries commit to Ukraine deployment if peace agreed
-
White House quietly drops WTO, ILO from foreign aid cut list
-
Wales edge Kazakhstan to boost World Cup hopes
-
Ayuso sprints to Vuelta stage 12 victory as tensions ease
-
Could humans become immortal, as Putin was heard telling Xi?
-
Stock markets advance with eyes on US jobs data
-
Xi tells Kim North Korea's importance to China 'will not change'
-
France detains seven over new cryptocurrency kidnapping
-
Europe pledges postwar 'reassurance force' for Ukraine: Macron
-
Hollywood hails Armani, designer to the stars
-
RFK Jr defends health agency shake up, Democrats call for his ouster
-
Bike-loving Dutch weigh ban on fat bikes from cycle lanes
-
With restraint, Armani stitched billion-dollar fashion empire
-
France, Switzerland agree on Rhone, Lake Geneva water management
-
US trade gap widest in 4 months as imports surged ahead of tariffs
-
Portugal mourns 16 killed in Lisbon funicular crash
-
Alarm in Germany as 'dangerous' Maddie suspect set to walk
-
Italian fashion icon Giorgio Armani dead at 91
-
Pro-Palestinian protests rock Spain's Vuelta cycling race
-
Tourists and locals united in grief after Lisbon funicular crash
-
Comedy writer at centre of UK free-speech row in court on harassment charge
-
Europe leaders call Trump after Ukraine security guarantees summit
-
French museum hit by 9.5 mn euro porcelain heist
-
Berlusconi media group takes control of German broadcaster
-
European court faults France over sexual consent rules
-
Rain adds to misery of Afghan quake survivors
-
Rubio eyes tough-security ally in Ecuador
-
Afghanistan quake deadliest in decades, killing over 2,200
-
Coffee and cash: how Hamas pays its civil servants in secret
-
Stock markets mixed with eyes on US jobs data
-
China's Xi holds talks with North Korea's Kim in Beijing
-
Seniors back to work as ageing Germany battles pension burden
-
Spence on brink of history as first Muslim England player
-
Portugal holds day of mourning as crash toll rises to 17 dead
-
Taiwan star Shu Qi channels her childhood trauma into directorial debut
-
France's Ozon under the gun with big screen take on Camus classic
-
Zelensky meets European leaders on Ukraine security guarantees
-
Kolisi returns but won't captain Springboks against All Blacks
-
French women's boxing team barred from world champs over late gender test results
-
Asia markets mixed as Chinese stocks lose steam
-
'Biggest' Women's Asian Cup can help drive change, says top official
-
Searchers retrieve bodies as Afghan quake toll expected to rise
-
China's Xi at centre of world stage after days of high-level hobnobbing
-
Australia's Schmidt warns of 'super tough' Argentina test
-
Daniel Craig leads Hollywood stars to Toronto for 50th film fest
-
Trump admin asks Supreme Court for 'expedited' ruling on tariffs
NYSE - LSE
| CMSD | 0.21% | 23.92 | $ | |
| BCC | 1.81% | 85.52 | $ | |
| GSK | -0.01% | 39.355 | $ | |
| CMSC | 0.58% | 23.918 | $ | |
| AZN | -0.59% | 81.63 | $ | |
| SCS | 0.74% | 16.955 | $ | |
| BTI | 0.55% | 55.385 | $ | |
| NGG | 0.1% | 68.64 | $ | |
| JRI | 0.04% | 13.545 | $ | |
| RIO | -0.31% | 62.29 | $ | |
| RBGPF | 0% | 71.48 | $ | |
| BP | 0.01% | 34.465 | $ | |
| BCE | -0.02% | 24.525 | $ | |
| RYCEF | -2.22% | 14.4 | $ | |
| RELX | 2.08% | 46.795 | $ | |
| VOD | 0.3% | 11.735 | $ |
Lunai Bioworks Inc. Retains American Defense International
Collaboration aims to apply Lunai Bioworks Inc. biomedical AI platform to accelerate countermeasure development for chemical agents like sarin and other biothreats
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 4, 2025 / Lunai Bioworks Inc. DBA Renovaro Inc. (NASDAQ:RENB), Lunai Bioworks Inc. is an AI-powered tech bio company pioneering safe and responsible generative biology. With proprietary chemical datasets, advanced machine learning, and a focus on dual-use risk management, Lunai is redefining how artificial intelligence can accelerate therapeutic innovation while safeguarding society from emerging threats, today announced that it had retained American Defense International, Inc. (ADI), a leading Washington, D.C.-based consulting and government affairs firm specializing in defense and national security.
This collaboration is designed to support U.S. government agencies in the development of advanced countermeasures against chemical and biological weapons, including highly toxic agents such as sarin nerve gas. Lunai and ADI will work together to position Lunai's proprietary AI-enabled biomedical data platforms as key assets in identifying, testing, and accelerating the development of protective and therapeutic responses to emerging national security threats.
"Our mission is to leverage technology to protect and enhance human health," said David Weinstein, CEO of Lunai Bioworks Inc. "In an era of rising geopolitical instability and biothreat risk, we believe our predictive platforms can offer government agencies critical tools to respond more rapidly and effectively to chemical and biological weapon threats."
American Defense International will serve as Lunai's strategic advisor in Washington, helping to align Lunai's capabilities with key government initiatives, including programs within the Department of Defense (DoD), the Biomedical Advanced Research and Development Authority (BARDA),The Defense Advanced Research Projects Agency (DARPA) and other biodefense and homeland security stakeholders.
"We are proud to work with Lunai Bioworks Inc. to support the U.S. government's preparedness and response efforts against weapons of mass destruction," said Van Hipp, Chairman of American Defense International. "Lunai's technology is uniquely suited to accelerate discovery and deployment of lifesaving interventions in scenarios where time and precision are critical."
Lunai's AI platform is already used in clinical and pharmaceutical settings to harmonize complex, multi-source biomedical data and improve predictive accuracy. This relationship marks a strategic extension of its capabilities into defense and biodefense applications.
About Lunai Bioworks Inc. DBA Renovaro (NASDAQ:RENB)
Lunai Bioworks Inc. is an AI-powered tech bio company pioneering safe and responsible generative biology. With proprietary chemical datasets, advanced machine learning, and a focus on dual-use risk management, Lunai is redefining how artificial intelligence can accelerate therapeutic innovation while safeguarding society from emerging threats.
About American Defense International, Inc.
American Defense International, Inc. (ADI) is a premier government affairs and business development firm based in Washington, D.C. With decades of experience, ADI provides strategic counsel and representation in national security, defense, and energy sectors, supporting clients in engaging effectively with the U.S. government.
Contact:
David Weinstein
Chief Executive Officer
[email protected]
www.renovarogroup.com
SOURCE: Renovaro Biosciences
View the original press release on ACCESS Newswire
P.M.Smith--AMWN
